No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Nevisense is a market within the oncology field that focuses on the early detection of cancer. It is based on the use of electrical impedance spectroscopy (EIS) to detect changes in tissue electrical properties. This technology is used to detect cancerous cells in the body, allowing for early diagnosis and treatment. It is a non-invasive procedure that is used to detect cancer in the breast, prostate, and other organs.
The Nevisense market is growing rapidly as it provides a more accurate and cost-effective way to detect cancer. It is also being used to monitor the progression of cancer and to assess the effectiveness of treatments.
Some companies in the Nevisense market include Nevisense AB, Nevisense USA, and Nevisense Asia. These companies are focused on developing and commercializing the technology to make it more accessible to patients. They are also working to improve the accuracy and reliability of the technology. Show Less Read more
